When was Chronomics founded?

Chronomics was founded in 2017 and raised its 1st funding round 2 years after it was founded.

Where is Chronomics located?

Chronomics is headquartered in Norwich, United Kingdom.

Which legal entities is Chronomics associated with?

Chronomics is associated with CHRONOMICS LIMITED.

How many employees does Chronomics have?

As of Mar 31, 2026, the latest employee count at Chronomics is 72.

Is Chronomics a funded company?

Chronomics is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Jan 10, 2019.

When was the latest funding round of Chronomics?

Chronomics' latest funding was a $***** Seed round on Jan 10, 2019, with participation from 2 investors. Its primary sector is Genomics. In United Kingdom, the Genomics sector has seen $66.7M in funding in 2026 to date.

Where does Chronomics rank among its competitors?

Chronomics ranks 8th amongst 26 active competitors, of which 10 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was EpiCypher, which secured $2.02M in Sep, 2025.

Who are the top competitors of Chronomics?

Chronomics' top competitors include Biomodal, FOXO Technologies and Moonwalk. Among them, EpiCypher secured the most recent funding round in September, 2025.

Chronomics - 2026 Company Profile, Team, Funding, Competitors & Financials

Chronomics is a seed company based in Norwich (United Kingdom), founded in 2017. It operates as a Provider of an online digital platform for epigenetics data. Chronomics has raised $1.43M in funding from Anthemis Group and SOSV. The company has 26 active competitors, including 10 funded and 4 that have exited. Its top competitors include companies like Biomodal, FOXO Technologies and Moonwalk.

Company Details

Provider of an online digital platform for epigenetics data. The platform offers proactive healthcare analysis by the DNA-based epigenetic tests by collecting the sample from the home-based saliva test.

Website: chronomics.com
Social
Email ID: *****@chronomics.co.uk
Phone Number: +44 **********

Key Metrics

Founded Year

2017

Location

Norwich, United Kingdom

Stage

Seed

Total Funding

$1.43M in 1 round

Latest Funding Round

Seed, Jan 10, 2019, $*****

Investors

Anthemis Group & 4 more

Ranked

8^th among 26 active competitors

Employee Count

72 as on Mar 31, 2026

Similar Companies

Biomodal & 28 more

View Chronomics' full profile

Chronomics is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
CHRONOMICS LIMITED CIN: 11120038 , United Kingdom, Active		-	33 (As on Dec 31, 2024)

Chronomics has raised a total funding of $1.43M over 1 round. Its latest funding round was a Seed round on Jan 10, 2019 for $*****. 2 investors participated in its latest round. Chronomics has 3 institutional investors and 2 angel investors.

Here is the list of recent funding rounds of Chronomics:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 10, 2019	1884589	Seed	5554826	8594757	5946743	2383903

Access funding benchmarks and valuations. Sign up today!

View details of Chronomics's funding rounds and investors

Chronomics' employee count trend

Chronomics has 72 employees as of Mar 26. Here is Chronomics's employee count trend over the years:

Uncover Chronomics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Chronomics include Biomodal, FOXO Technologies and Moonwalk. Here is the list of Top 10 competitors of Chronomics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Biomodal 2012, Cambridge (United Kingdom), Series D	Developer of a duet multiomics platform that generates genetic and epigenetic data	$164M	Temasek, Google Ventures & 23 others	63/100
2nd	FOXO Technologies 2020, Minneapolis (United States), Public	Provider of epigenetic biomarkers discovery and development platform	$40M	Bespoke Growth Partners, Inc., Centrecourt Asset Management ... Read more	60/100
3rd	Moonwalk 2022, San Francisco (United States), Series A	Digital platform pioneering precision epigenetic medicines	$57M	Khosla Ventures, Future Ventures & 3 others	60/100
4th	EpiCypher 2012, Chapel Hill (United States), Series A	Provider of epigentic kits, reagents and assays for research purpose	$3.43M	NCBiotech, HHS	57/100
5th	Active Motif 1999, Carlsbad (United States), Funding Raised	Provider of research kits, assays and biocomputing systems	-	Broadoak Capital Partners, National Science Foundation ... & 1 others	51/100
6th	Epigenica 2020, Stockholm (Sweden), Seed	Provider of solutions for the analysis of genomic data	$2.2M	Voima Ventures, Leksell Social Ventures & 4 others	46/100
7th	Chroma Medicine 2020, Cambridge (United States), Series B	Developer of an epigenetic editing platform for genomic medicines	$260M	Cormorant-asset, Google Ventures & 16 others	44/100
8th	Chronomics 2017, Norwich (United Kingdom), Seed	Provider of an online digital platform for epigenetics data	$1.43M	Anthemis Group, SOSV & 3 others	42/100
9th	Reaction Biology 2001, United States, Late Stage	In vitro enzyme activity assays, secializing in kinase & epigenetic HTS and profiling	-	Cobepa, CYwP Funds & 6 others	40/100
10th	Inherent Biosciences 2019, Salt Lake City (United States), Series A	Developer of epigenetic diagnostics and therapeutics for complex diseases	-	morningstar.foundation, Propel Bio Partners ... & 12 others	37/100